HIT Consultant

AUGUST 5, 2022

What You Should Know: – The index of Healthcare & Life Science equities tracked by Stout was down 16.8% – Healthcare & Life Science M&A activity plummeted to 338 deals in Q2 2022 versus 535 in Q2 2021 and a record 565 deals in Q4 2021. Medical Device equities were down 18.5%

Life Sciences 98

Life Sciences Telemedicine Healthcare Biotechnology 98

HIT Consultant

NOVEMBER 18, 2021

Benchling , a San Francisco, CA-based life and sciences R&D cloud platform raises $100M in Series F funding at a $6B valuation, co-led by new investor Franklin Templeton and existing investor Altimeter Capital , and joined by new investors Tiger Global and Lone Pine Capital , as well as existing investors.

Biotechnology 97

Biotechnology Life Sciences Pharmaceuticals Accountability 97

HIT Consultant

JANUARY 28, 2022

Benchling , pioneer of the R&D Cloud powering the biotechnology industry appoints Paul Robson, a cloud veteran as President of Field Operations and Elena Donio, the former CEO of Axiom and President of Concur, to its board, as a director and compensation committee chair. . – Leah Ray , Chief Customer Officer.

Biotechnology 98

Biotechnology Life Sciences Private Practices Healthcare Analytics 98